Moberg Pharma AB Balance Sheet

Financials in millions SEK. Fiscal year is January - December.

Millions SEK. Fiscal year is Jan - Dec.

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Mar '26 Mar 31, 2026	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021
Cash & Equivalents	222.5	230.95	293.29	60.56	125.55	102.66
Cash & Short-Term Investments	222.5	230.95	293.29	60.56	125.55	102.66
Cash Growth	-17.26%	-21.25%	384.33%	-51.77%	22.30%	432.28%
Accounts Receivable	6.7	2.33	0.17	-	0.38	0.47
Other Receivables	-	0.37	0.64	0.79	1.06	0.66
Receivables	6.7	2.7	0.8	0.79	1.44	1.14
Inventory	5.79	3.58	4.3	7.12	-	-
Prepaid Expenses	-	0.62	1.58	0.9	0.72	0.75
Other Current Assets	-	0.06	0.14	0.14	0.06	0.12
Total Current Assets	234.99	237.91	300.11	69.49	127.76	104.66
Property, Plant & Equipment	2.41	2.81	4.42	4.94	5.98	4.52
Other Intangible Assets	353.54	-	-	-	-	-
Long-Term Deferred Tax Assets	92.55	92.58	95.78	28.08	22.58	14.67
Long-Term Deferred Charges	-	348.96	305.77	532.22	408.1	327.04
Total Assets	683.48	682.26	706.09	634.73	564.42	450.89
Accounts Payable	-	2.93	4.16	6.77	17.11	5.31
Accrued Expenses	-	11.19	10.67	12.5	7.56	7.45
Current Portion of Leases	1.7	1.68	1.6	1.27	2.12	2.7
Other Current Liabilities	16.21	0.38	0.29	-	-	0.09
Total Current Liabilities	17.91	16.17	16.72	20.54	26.79	15.54
Long-Term Leases	0.44	0.87	2.55	3.47	3.99	1.24
Other Long-Term Liabilities	-	-	-	-	0.07	0.07
Total Liabilities	18.34	17.04	19.27	24.01	30.84	16.84
Common Stock	665.14	47	46.69	27.96	9.83	4.41
Additional Paid-In Capital	-	1,239	1,234	921.3	841.2	731.38
Retained Earnings	-	-620.88	-593.64	-338.53	-317.44	-301.73
Total Common Equity	665.14	665.22	686.82	610.73	533.58	434.05
Shareholders' Equity	665.14	665.22	686.82	610.73	533.58	434.05
Total Liabilities & Equity	683.48	682.26	706.09	634.73	564.42	450.89
Total Debt	2.14	2.55	4.14	4.74	6.11	3.93
Net Cash (Debt)	220.36	228.4	289.15	55.82	119.45	98.72
Net Cash Growth	-16.89%	-21.01%	418.02%	-53.27%	20.99%	730.24%
Net Cash Per Share	4.81	4.88	7.64	3.52	15.74	22.94
Filing Date Shares Outstanding	42.1	47	46.69	27.96	9.83	4.4
Total Common Shares Outstanding	42.1	47	46.69	27.96	9.83	4.4
Working Capital	217.08	221.74	283.39	48.95	100.97	89.12
Book Value Per Share	15.80	14.15	14.71	21.84	54.30	98.54
Tangible Book Value	311.6	665.22	686.82	610.73	533.58	434.05
Tangible Book Value Per Share	7.40	14.15	14.71	21.84	54.30	98.54

Source: S&P Global Market Intelligence. Standard template. Financial Sources.